Cannabis in Pregnancy UK — Risks, NHS Advice, and Complete Guide

Cannabis use during pregnancy remains a significant public health concern in the United Kingdom. Despite increasing legalisation of medical cannabis in certain circumstances, current evidence and NHS guidance strongly advise against cannabis consumption during pregnancy and breastfeeding. This comprehensive guide provides UK expectant mothers, partners, and healthcare professionals with evidence-based information about cannabis in pregnancy.

What Does the NHS Recommend About Cannabis in Pregnancy?

The NHS explicitly recommends that all pregnant women and those planning pregnancy should avoid cannabis entirely. This guidance applies to all forms of cannabis, including recreational use, medical cannabis, and products containing CBD (cannabidiol). The National Institute for Health and Care Excellence (NICE) emphasises that cannabis use during pregnancy poses potential risks to fetal development and long-term child health outcomes.

The Royal College of Obstetricians and Gynaecologists (RCOG) and the Royal College of Midwives (RCM) align with NHS guidance, recommending complete abstinence from cannabis during pregnancy and whilst breastfeeding. Women who have used cannabis before discovering their pregnancy should discuss this openly with their healthcare provider to assess individual risks and provide appropriate monitoring.

How Does Cannabis Affect Fetal Development?

THC (tetrahydrocannabinol), the primary psychoactive compound in cannabis, crosses the placental barrier and reaches the developing fetus. Research demonstrates that THC can interfere with crucial neurodevelopmental processes during critical windows of brain development. The fetal brain is particularly vulnerable to external substances during the second and third trimesters.

Studies indicate that prenatal cannabis exposure may affect:

• Neural development and brain structure formation
• Neurotransmitter function and signalling
• Growth patterns and birth weight
• Cognitive development and learning capacity
• Behaviour and attention regulation

Research from the University of Bristol following over 11,000 children found that maternal cannabis use during pregnancy was associated with increased risk of behavioural problems in childhood, with effects potentially persisting into later development.

What Are the Health Risks for the Baby?

Evidence consistently links prenatal cannabis exposure to several adverse outcomes. Babies born to mothers who used cannabis during pregnancy show increased risk of:

Low Birth Weight: Multiple studies report that cannabis exposure is associated with reduced fetal growth and lower birth weights, which itself carries health complications including difficulties regulating temperature and increased infection risk.

Premature Birth: Some research suggests associations between cannabis use and earlier delivery, although evidence remains mixed. Premature birth presents significant health challenges for newborns requiring intensive care.

Developmental Delays: Long-term studies indicate children exposed to cannabis in utero may experience delays in cognitive development, language acquisition, and motor skills development compared to unexposed peers.

Neurobehavioural Issues: Children born to cannabis-using mothers demonstrate higher rates of attention difficulties, impulse control problems, and social interaction challenges, particularly during school-age years.

A comprehensive review published in the British Medical Journal concluded that the overall evidence demonstrates cannabis use in pregnancy is harmful to fetal development, with effects potentially lasting into adolescence and adulthood.

Understanding THC and CBD in Pregnancy

Many pregnant women mistakenly believe CBD (cannabidiol) is safe during pregnancy because it is non-intoxicating. However, NHS guidance does not distinguish between CBD and THC—both should be avoided. CBD products may contain variable amounts of THC, and research on CBD safety in pregnancy remains limited.

Although medical cannabis is now available through NHS prescription in specific circumstances (usually severe epilepsy, chemotherapy-related nausea, or spasticity from multiple sclerosis), pregnant women cannot legally access NHS-prescribed cannabis. Any woman of reproductive age taking medical cannabis should discuss contraception and family planning with their prescribing physician.

Cannabis Use Statistics in UK Pregnancy

Data on cannabis use amongst UK pregnant women remains incomplete, though research suggests prevalence varies by demographic factors. Surveys indicate that approximately 2-3% of pregnant women in the UK have used cannabis during pregnancy, though actual figures may be underestimated due to stigma and underreporting.

Women aged 18-24 demonstrate higher cannabis use rates generally, though use during pregnancy is less common. Socioeconomic factors and access to prenatal care affect both use patterns and reporting accuracy.

What Should You Do If You’ve Used Cannabis During Pregnancy?

If you have used cannabis during pregnancy, either before recognising pregnancy or during early pregnancy, the most important step is informing your midwife or GP. Healthcare professionals must maintain confidentiality and cannot report drug use unless child safeguarding concerns emerge. Honest communication enables:

• Appropriate fetal monitoring and ultrasound assessment
• Risk stratification and individualised care planning
• Access to specialist services if required
• Support to cease cannabis use and maintain abstinence
• Enhanced postnatal monitoring if indicated

Your healthcare team can arrange additional scans to monitor fetal development and provide tailored advice based on timing, frequency, and quantity of use. Many pregnancies proceed normally despite early cannabis exposure, though careful monitoring provides reassurance.

Supporting Cannabis Cessation in Pregnancy

For pregnant women struggling with cannabis dependence, NHS services provide evidence-based support. Drug and alcohol services across the UK offer specialist maternity support, helping women reduce and stop cannabis use safely during pregnancy without harmful withdrawal effects.

Behavioural support, psychosocial interventions, and counselling prove most effective. Unlike some substances, cannabis withdrawal is not medically dangerous but causes irritability, sleep disruption, and anxiety. Healthcare professionals help manage these symptoms whilst protecting maternal and fetal health.

Breastfeeding and Cannabis

THC passes into breast milk and concentrates in fatty tissue, potentially exposing infants during breastfeeding. The NHS advises against cannabis use whilst breastfeeding. Women using cannabis should not breastfeed, as developing infants cannot metabolise THC effectively, creating potential for accumulation and harmful effects on brain development during critical postnatal periods.

Key Takeaway Messages

Cannabis use during pregnancy carries documented risks to fetal development and long-term child health. NHS guidance, supported by major medical professional bodies, recommends complete abstinence. If you are pregnant or planning pregnancy and have concerns about cannabis use, contact your GP or midwife for confidential, non-judgmental support. Evidence-based interventions help achieve and maintain abstinence, protecting your baby’s health and development.